Protein C system defects inflicted by the malaria parasite protein PfEMP1 can be overcome by a soluble EPCR variant

 

 Buy Article Permissions and Reprints

Summary

The Endothelial Protein C receptor (EPCR) is essential for the anticoagulant and cytoprotective functions of the Protein C (PC) system. Selected variants of the malaria parasite protein, Plasmodium falciparum Erythrocyte Membrane Protein 1 (PfEMP1) associated with severe malaria, including cerebral malaria, specifically target EPCR on vascular endothelial cells. Here, we examine the cellular response to PfEMP1 engagement to elucidate its role in malaria pathogenesis. Binding of the CIDRα1.1 domain of PfEMP1 to EPCR obstructed activated PC (APC) binding to EPCR and induced a loss of cellular EPCR functions. CIDRα1.1 severely impaired endothelial PC activation and effectively blocked APC-mediated activation of protease-activated receptor-1 (PAR1) and associated barrier protective effects of APC on endothelial cells. A soluble EPCR variant (E86A-sEPCR) bound CIDRα1.1 with high affinity and did not interfere with (A)PC binding to cellular EPCR. E86A-sEPCR used as a decoy to capture PfEMP1, permitted normal PC activation on endothelial cells, normal barrier protective effects of APC, and greatly reduced cytoadhesion of infected erythrocytes to brain endothelial cells. These data imply important contributions of PfEMP1-induced protein C pathway defects in the pathogenesis of severe malaria. Furthermore, the E86A-sEPCR decoy provides a proof-of-principle strategy for the development of novel adjunct therapies for severe malaria.

^§ These authors contributed equally to the work.

• References

• 1 Carme B, Bouquety JC, Plassart H.. Mortality and sequelae due to cerebral malaria in African children in Brazzaville, Congo. Am J Trop Med Hyg 1993; 48: 216-221.
  CrossrefPubMedGoogle Scholar
• 2 Birbeck GL, Molyneux ME, Kaplan PW. et al. Blantyre Malaria Project Epilepsy Study (BMPES) of neurological outcomes in retinopathy-positive paediatric cerebral malaria survivors: a prospective cohort study. Lancet Neurol 2010; 9: 1173-1181.
  CrossrefPubMedGoogle Scholar
• 3 Moxon CA, Heyderman RS, Wassmer SC. Dysregulation of coagulation in cerebral malaria. Mol Biochem Parasitol 2009; 166: 99-108.
  CrossrefPubMedGoogle Scholar
• 4 Storm J, Craig AG. Pathogenesis of cerebral malaria--inflammation and cytoadherence. Front Cell Infect Microbiol 2014; 4: 100.
  PubMedGoogle Scholar
• 5 Lavstsen T, Turner L, Saguti F. et al. Plasmodium falciparum erythrocyte membrane protein 1 domain cassettes 8 and 13 are associated with severe malaria in children. Proc Natl Acad Sci USA 2012; 109: E1791-1800.
  CrossrefPubMedGoogle Scholar
• 6 Turner L, Lavstsen T, Berger SS. et al. Severe malaria is associated with parasite binding to endothelial protein C receptor. Nature 2013; 498: 502-505.
  CrossrefPubMedGoogle Scholar
• 7 Rowe JA, Claessens A, Corrigan RA. et al. Adhesion of Plasmodium falciparum-infected erythrocytes to human cells: molecular mechanisms and therapeutic implications. Exp Rev Mol Med 2009; 11: e16.
  CrossrefPubMedGoogle Scholar
• 8 Fukudome K, Esmon CT. Identification, cloning, and regulation of a novel endothelial cell protein C/activated protein C receptor. J Biol Chem 1994; 269: 26486-26491.
  PubMedGoogle Scholar
• 9 Lopez-Sagaseta J, Montes R, Puy C. et al. Binding of factor VIIa to the endothelial cell protein C receptor reduces its coagulant activity. J Thromb Haemost 2007; 5: 1817-1824.
  CrossrefPubMedGoogle Scholar
• 10 Bouwens EA, Stavenuiter F, Mosnier LO. Mechanisms of anticoagulant and cytoprotective actions of the protein C pathway. J Thromb Haemost 2013; 11 (Suppl 1) 242-253.
  CrossrefPubMedGoogle Scholar
• 11 Vatsyayan R, Kothari H, Mackman N. et al. Inactivation of Factor VIIa by Antithrombin In Vitro, Ex Vivo and In Vivo: Role of Tissue Factor and Endothelial Cell Protein C Receptor. PloS one 2014; 9: e103505.
  CrossrefPubMedGoogle Scholar
• 12 Mohan Rao LV, Esmon CT, Pendurthi UR. Endothelial cell protein C receptor: a multiliganded and multifunctional receptor. Blood 2014; 124: 1553-1562.
  CrossrefPubMedGoogle Scholar
• 13 Mosnier LO, Zlokovic BV, Griffin JH. The cytoprotective protein C pathway. Blood 2007; 109: 3161-3172.
  CrossrefPubMedGoogle Scholar
• 14 Stearns-Kurosawa DJ, Kurosawa S, Mollica JS. et al. The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex. Proc Natl Acad Sci USA 1996; 93: 10212-10216.
  CrossrefPubMedGoogle Scholar
• 15 Esmon CT. The protein C pathway. Chest 2003; 124 (3 Suppl) 26S-32S.
  CrossrefPubMedGoogle Scholar
• 16 Esmon CT. The endothelial protein C receptor. Curr Opin Hematol 2006; 13: 382-385.
  CrossrefPubMedGoogle Scholar
• 17 Burnier L, Mosnier LO. Novel mechanisms for activated protein C cytoprotective activities involving noncanonical activation of protease-activated receptor 3. Blood 2013; 122: 807-816.
  CrossrefPubMedGoogle Scholar
• 18 Mosnier LO, Sinha RK, Burnier L. et al. Biased agonism of protease-activated receptor 1 by activated protein C caused by noncanonical cleavage at Arg46. Blood 2012; 120: 5237-5246.
  CrossrefPubMedGoogle Scholar
• 19 Zlokovic BV, Griffin JH. Cytoprotective protein C pathways and implications for stroke and neurological disorders. Trends Neurosci 2011; 34: 198-209.
  CrossrefPubMedGoogle Scholar
• 20 Mosnier LO, Zlokovic BV, Griffin JH. Cytoprotective-selective activated protein C therapy for ischaemic stroke. Thromb Haemost 2014; 112: 883-892.
  Article in Thieme ConnectPubMedGoogle Scholar
• 21 Moxon CA, Wassmer SC, Milner Jr. DA. et al. Loss of endothelial protein C receptors links coagulation and inflammation to parasite sequestration in cerebral malaria in African children. Blood 2013; 122: 842-851.
  CrossrefPubMedGoogle Scholar
• 22 Hemmer CJ, Kern P, Holst FG. et al. Activation of the host response in human Plasmodium falciparum malaria: relation of parasitemia to tumor necrosis factor/cachectin, thrombin-antithrombin III, and protein C levels. Am J Med 1991; 91: 37-44.
  CrossrefPubMedGoogle Scholar
• 23 Mosnier LO. Platelet factor 4 inhibits thrombomodulin-dependent activation of thrombin-activatable fibrinolysis inhibitor (TAFI) by thrombin. J Biol Chem 2011; 286: 502-510.
  CrossrefPubMedGoogle Scholar
• 24 Bouwens EA, Stavenuiter F, Mosnier LO. Cell painting with an engineered EPCR to augment the protein C system. Thromb Haemost. 2015 Epub ahead of print.
  PubMedGoogle Scholar
• 25 Mosnier LO, Zampolli A, Kerschen EJ. et al. Hyperantithrombotic, noncytoprotective Glu149Ala-activated protein C mutant. Blood 2009; 113: 5970-5978.
  CrossrefPubMedGoogle Scholar
• 26 Stins MF, Gilles F, Kim KS. Selective expression of adhesion molecules on human brain microvascular endothelial cells. J Neuroimmunol 1997; 76: 81-90.
  CrossrefPubMedGoogle Scholar
• 27 Ye X, Fukudome K, Tsuneyoshi N. et al. The endothelial cell protein C receptor (EPCR) functions as a primary receptor for protein C activation on endothelial cells in arteries, veins, and capillaries. Biochem Biophys Res Comun 1999; 259: 671-677.
  CrossrefPubMedGoogle Scholar
• 28 Schindelin J, Arganda-Carreras I, Frise E. et al. Fiji: an open-source platform for biological-image analysis. Nature Methods 2012; 9: 676-682.
  CrossrefPubMedGoogle Scholar
• 29 Liaw PC, Mather T, Oganesyan N. et al. Identification of the protein C/activated protein C binding sites on the endothelial cell protein C receptor. Implications for a novel mode of ligand recognition by a major histocompatibility complex class 1-type receptor. J Biol Chem 2001; 276: 8364-8370.
  CrossrefPubMedGoogle Scholar
• 30 Preston RJ, Villegas-Mendez A, Sun YH. et al. Selective modulation of protein C affinity for EPCR and phospholipids by Gla domain mutation. FEBS J 2005; 272: 97-108.
  PubMedGoogle Scholar
• 31 Otto TD, Rayner JC, Bohme U. et al. Genome sequencing of chimpanzee malaria parasites reveals possible pathways of adaptation to human hosts. Nature Commun 2014; 5: 4754.
  CrossrefPubMedGoogle Scholar
• 32 Craig AG, Grau GE, Janse C. et al. The role of animal models for research on severe malaria. PLoS Pathogens 2012; 8: e1002401.
  CrossrefPubMedGoogle Scholar
• 33 Li W, Zheng X, Gu JM. et al. Extraembryonic expression of EPCR is essential for embryonic viability. Blood 2005; 106: 2716-2722.
  CrossrefPubMedGoogle Scholar
• 34 Zheng X, Li W, Gu JM. et al. Effects of membrane and soluble EPCR on the hemostatic balance and endotoxemia in mice. Blood 2007; 109: 1003-1009.
  PubMedGoogle Scholar
• 35 Castellino FJ, Liang Z, Volkir SP. et al. Mice with a severe deficiency of the endothelial protein C receptor gene develop, survive, and reproduce normally, and do not present with enhanced arterial thrombosis after challenge. Thromb Haemost 2002; 88: 462-472.
  Article in Thieme ConnectPubMedGoogle Scholar
• 36 Taylor Jr. FB, Peer GT, Lockhart MS. et al. Endothelial cell protein C receptor plays an important role in protein C activation in vivo. Blood 2001; 97: 1685-1688.
  CrossrefPubMedGoogle Scholar
• 37 Centelles MN, Puy C, Lopez-Sagaseta J. et al. Blocking endothelial protein C receptor (EPCR) accelerates thrombus development in vivo. Thromb Haemost 2010; 103: 1239-1244.
  Article in Thieme ConnectPubMedGoogle Scholar
• 38 Tamayo I, Velasco SE, Puy C. et al. sPLA2-V impairs EPCR-dependent protein C activation and accelerates thrombosis in vivo. J Thromb Haemost 2014; 12: 1921-1927.
  CrossrefPubMedGoogle Scholar
• 39 Cushman M. Inherited risk factors for venous thrombosis. Hematology / the Education Program of the American Society of Hematology American Society of Hematology Education Program 2005; 452-457.
  PubMedGoogle Scholar
• 40 Clemens R, Pramoolsinsap C, Lorenz R. et al. Activation of the coagulation cascade in severe falciparum malaria through the intrinsic pathway. Br J Haematol 1994; 87: 100-105.
  CrossrefPubMedGoogle Scholar
• 41 Kerschen EJ, Fernandez JA, Cooley BC. et al. Endotoxemia and sepsis mortality reduction by non-anticoagulant activated protein C. The J Exp Med 2007; 204: 2439-2448.
  PubMedGoogle Scholar
• 42 Taylor Jr. FB, Stearns-Kurosawa DJ, Kurosawa S. et al. The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis. Blood 2000; 95: 1680-1686.
  PubMedGoogle Scholar
• 43 von Drygalski A, Furlan-Freguia C, Ruf W. et al. Organ-specific protection against lipopolysaccharide-induced vascular leak is dependent on the endothelial protein C receptor. Arterioscl Thromb Vasc Biol 2013; 33: 769-776.
  CrossrefPubMedGoogle Scholar
• 44 Naka I, Patarapotikul J, Hananantachai H. et al. Association of the endothelial protein C receptor (PROCR) rs867186-G allele with protection from severe malaria. Malaria J 2014; 13: 105.
  CrossrefPubMedGoogle Scholar
• 45 Qu D, Wang Y, Song Y. et al. The Ser219→Gly dimorphism of the endothelial protein C receptor contributes to the higher soluble protein levels observed in individuals with the A3 haplotype. J Thromb Haemost 2006; 4: 229-235.
  CrossrefPubMedGoogle Scholar
• 46 Saposnik B, Reny JL, Gaussem P. et al. A haplotype of the EPCR gene is associated with increased plasma levels of sEPCR and is a candidate risk factor for thrombosis. Blood 2004; 103: 1311-1318.
  PubMedGoogle Scholar
• 47 Fukudome K, Kurosawa S, Stearns-Kurosawa DJ. et al. The endothelial cell protein C receptor. Cell surface expression and direct ligand binding by the soluble receptor. J Biol Chem 1996; 271: 17491-17498.
  CrossrefPubMedGoogle Scholar
• 48 Regan LM, Stearns-Kurosawa DJ, Kurosawa S. et al. The endothelial cell protein C receptor. Inhibition of activated protein C anticoagulant function without modulation of reaction with proteinase inhibitors. J Biol Chem 1996; 271: 17499-17503.
  CrossrefPubMedGoogle Scholar
• 49 Liaw PC, Neuenschwander PF, Smirnov MD. et al. Mechanisms by which soluble endothelial cell protein C receptor modulates protein C and activated protein C function. J Biol Chem 2000; 275: 5447-5452.
  CrossrefPubMedGoogle Scholar
• 50 Holash J, Davis S, Papadopoulos N. et al. VEGF-Trap: a VEGF blocker with potent antitumor effects. Proc Natl Acad Sci USA 2002; 99: 11393-11398.
  CrossrefPubMedGoogle Scholar
• 51 Lu G, DeGuzman FR, Hollenbach SJ. et al. A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa. Nature Med 2013; 19: 446-451.
  CrossrefPubMedGoogle Scholar
• 52 Schuepbach RA, Riewald M. Coagulation factor Xa cleaves protease-activated receptor-1 and mediates signaling dependent on binding to the endothelial protein C receptor. J Thromb Haemost 2010; 8: 379-388.
  CrossrefPubMedGoogle Scholar
• 53 Disse J, Petersen HH, Larsen KS. et al. The endothelial protein C receptor supports tissue factor ternary coagulation initiation complex signaling through protease-activated receptors. J Biol Chem 2011; 286: 5756-5767.
  CrossrefPubMedGoogle Scholar
• 54 Kurosawa S, Esmon CT, Stearns-Kurosawa DJ. The soluble endothelial protein C receptor binds to activated neutrophils: involvement of proteinase-3 and CD11b/CD18. J Immunol 2000; 165: 4697-4703.
  CrossrefPubMedGoogle Scholar
• 55 Fink K, Busch HJ, Bourgeois N. et al. Mac-1 directly binds to the endothelial protein C-receptor: a link between the protein C anticoagulant pathway and inflammation?. PloS one 2013; 8: e53103.
  CrossrefPubMedGoogle Scholar